Company profile for Tychan

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tychan is a clinical-stage biotechnology company focused on bringing life-saving treatments to those in need through disruptive technologies. We seek to reduce the development timeline of therapeutics leading to clinical application - a major unmet need in the context of infectious diseases. Our technology platform integrates convergent analytics with innovative manufacturing processes to enable rapid production of safe and ef...
Tychan is a clinical-stage biotechnology company focused on bringing life-saving treatments to those in need through disruptive technologies. We seek to reduce the development timeline of therapeutics leading to clinical application - a major unmet need in the context of infectious diseases. Our technology platform integrates convergent analytics with innovative manufacturing processes to enable rapid production of safe and effective biologics for human trials. The name Tychan (pronounced Tyk-AN), is derived from Tyche, the Greek goddess who governs the fortune and prosperity of a city and 安 (ān), meaning peace in Mandarin.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Singapore
Address
Address
1 Research Link, #04-31, National University of Singapore,
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20210617005787/en

BUSINESSWIRE
17 Jun 2021

https://www.businesswire.com/news/home/20201210006232/en/Tychan-to-Start-COVID-19-Phase-3-Clinical-Trial-For-Novel-Monoclonal-Antibody-TY027

BUSINESSWIRE
11 Dec 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty